Annual Total Liabilities
$31.15 M
+$19.35 M+164.03%
June 30, 2024
Summary
- As of February 7, 2025, RENB annual total liabilities is $31.15 million, with the most recent change of +$19.35 million (+164.03%) on June 30, 2024.
- During the last 3 years, RENB annual total liabilities has risen by +$16.21 million (+108.48%).
- RENB annual total liabilities is now at all-time high.
Performance
RENB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$23.75 M
-$7.41 M-23.78%
September 30, 2024
Summary
- As of February 7, 2025, RENB quarterly total liabilities is $23.75 million, with the most recent change of -$7.41 million (-23.78%) on September 30, 2024.
- Over the past year, RENB quarterly total liabilities has increased by +$12.93 million (+119.53%).
- RENB quarterly total liabilities is now -45.64% below its all-time high of $43.68 million, reached on March 31, 2024.
Performance
RENB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RENB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +164.0% | +119.5% |
| 3 y3 years | +108.5% | +119.5% |
| 5 y5 years | +359.6% | +119.5% |
RENB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.0% | -45.6% | +119.5% |
| 5 y | 5-year | at high | +359.6% | -45.6% | +235.5% |
| alltime | all time | at high | >+9999.0% | -45.6% | >+9999.0% |
Renovaro Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.75 M(-23.8%) |
| Jun 2024 | $31.15 M(+164.0%) | $31.15 M(-28.7%) |
| Mar 2024 | - | $43.68 M(+202.9%) |
| Dec 2023 | - | $14.42 M(+33.3%) |
| Sep 2023 | - | $10.82 M(-8.3%) |
| Jun 2023 | $11.80 M(-1.8%) | - |
| Jun 2023 | - | $11.80 M(-6.4%) |
| Mar 2023 | - | $12.60 M(-5.8%) |
| Dec 2022 | - | $13.37 M(+4.9%) |
| Sep 2022 | - | $12.75 M(+6.1%) |
| Jun 2022 | $12.01 M(-19.6%) | $12.01 M(-36.3%) |
| Mar 2022 | - | $18.86 M(+7.7%) |
| Dec 2021 | - | $17.52 M(+2.5%) |
| Sep 2021 | - | $17.09 M(+14.4%) |
| Jun 2021 | $14.94 M(+26.3%) | $14.94 M(+31.3%) |
| Mar 2021 | - | $11.38 M(+4.0%) |
| Dec 2020 | - | $10.94 M(+0.4%) |
| Sep 2020 | - | $10.90 M(-7.8%) |
| Jun 2020 | $11.83 M(+74.5%) | $11.83 M(+15.0%) |
| Mar 2020 | - | $10.29 M(+45.3%) |
| Dec 2019 | - | $7.08 M(-16.1%) |
| Sep 2019 | - | $8.44 M(+24.5%) |
| Jun 2019 | $6.78 M(-71.5%) | $6.78 M(-73.3%) |
| Mar 2019 | - | $25.34 M(+0.4%) |
| Dec 2018 | - | $25.24 M(+13.7%) |
| Sep 2018 | - | $22.21 M(-6.6%) |
| Jun 2018 | $23.76 M | $23.76 M(+2522.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $906.10 K(-84.8%) |
| Dec 2017 | - | $5.97 M(+528.0%) |
| Sep 2017 | - | $951.40 K(-68.2%) |
| Jun 2017 | $2.99 M(+98.2%) | $2.99 M(+50.3%) |
| Mar 2017 | - | $1.99 M(+15.9%) |
| Dec 2016 | - | $1.72 M(-1.6%) |
| Sep 2016 | - | $1.74 M(+15.5%) |
| Jun 2016 | $1.51 M(+51.5%) | $1.51 M(+44.5%) |
| Mar 2016 | - | $1.04 M(+16.8%) |
| Dec 2015 | - | $893.90 K(-11.8%) |
| Sep 2015 | - | $1.01 M(+4.3%) |
| Jun 2015 | $995.70 K(-43.4%) | - |
| Mar 2015 | - | $972.00 K(-44.7%) |
| Dec 2014 | $1.76 M(+2368.7%) | $1.76 M(-64.4%) |
| Sep 2014 | - | $4.93 M(+47.3%) |
| Jun 2014 | - | $3.35 M(+8.1%) |
| Mar 2014 | - | $3.10 M(+3806.2%) |
| Dec 2013 | - | $79.30 K(-5.4%) |
| Sep 2013 | - | $83.80 K(+24.0%) |
| Jun 2013 | - | $67.60 K(-5.1%) |
| Mar 2013 | $71.20 K(+161.8%) | $71.20 K(+29.7%) |
| Dec 2012 | - | $54.90 K(+16.1%) |
| Sep 2012 | - | $47.30 K(+23.8%) |
| Jun 2012 | - | $38.20 K(+40.4%) |
| Mar 2012 | $27.20 K(+212.6%) | $27.20 K(+20.4%) |
| Dec 2011 | - | $22.60 K |
| Mar 2011 | $8700.00 | - |
FAQ
- What is Renovaro Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences annual total liabilities year-on-year change?
- What is Renovaro Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly total liabilities year-on-year change?
What is Renovaro Biosciences annual total liabilities?
The current annual total liabilities of RENB is $31.15 M
What is the all time high annual total liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total liabilities is $31.15 M
What is Renovaro Biosciences annual total liabilities year-on-year change?
Over the past year, RENB annual total liabilities has changed by +$19.35 M (+164.03%)
What is Renovaro Biosciences quarterly total liabilities?
The current quarterly total liabilities of RENB is $23.75 M
What is the all time high quarterly total liabilities for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total liabilities is $43.68 M
What is Renovaro Biosciences quarterly total liabilities year-on-year change?
Over the past year, RENB quarterly total liabilities has changed by +$12.93 M (+119.53%)